| 纯度 | >90%SDS-PAGE. |
| 种属 | Human |
| 靶点 | PNPLA2 |
| Uniprot No | Q96AD5 |
| 内毒素 | < 0.01EU/μg |
| 表达宿主 | E.coli |
| 表达区间 | 1-504aa |
| 氨基酸序列 | MFPREKTWNISFAGCGFLGVYYVGVASCLREHAPFLVANATHIYGASAGALTATALVTGVCLGEAGAKFIEVSKEARKRFLGPLHPSFNLVKIIRSFLLKVLPADSHEHASGRLGISLTRVSDGENVIISHFNSKDELIQANVCSGFIPVYCGLIPPSLQGVRYVDGGISDNLPLYELKNTITVSPFSGESDICPQDSSTNIHELRVTNTSIQFNLRNLYRLSKALFPPEPLVLREMCKQGYRDGLRFLQRNGLLNRPNPLLALPPARPHGPEDKDQAVESAQAEDYSQLPGEDHILEHLPARLNEALLEACVEPTDLLTTLSNMLPVRLATAMMVPYTLPLESALSFTIRLLEWLPDVPEDIRWMKEQTGSICQYLVMRAKRKLGRHLPSRLPEQVELRRVQSLPSVPLSCAAYREALPGWMRNNLSLGDALAKWEECQRQLLLGLFCTNVAFPPEALRMRAPADPAPAPADPASPQHQLAGPAPLLSTPAPEARPVIGALGL |
| 预测分子量 | 71.3kDa |
| 蛋白标签 | His tag N-Terminus |
| 缓冲液 | PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300. |
| 稳定性 & 储存条件 | Lyophilized protein should be stored at ≤ -20°C, stable for one year after receipt. Reconstituted protein solution can be stored at 2-8°C for 2-7 days. Aliquots of reconstituted samples are stable at ≤ -20°C for 3 months. |
| 复溶 | Always centrifuge tubes before opening.Do not mix by vortex or pipetting. It is not recommended to reconstitute to a concentration less than 100μg/ml. Dissolve the lyophilized protein in distilled water. Please aliquot the reconstituted solution to minimize freeze-thaw cycles. |
以下是关于PNPLA2重组蛋白的3篇参考文献及其摘要内容的简要概括：
1. **文献名称**: "Recombinant PNPLA2 protein restores lipolysis in adipose triglyceride lipase-deficient cells"
**作者**: Zimmermann R, et al.
**摘要**: 该研究利用重组PNPLA2蛋白在ATGL缺陷的细胞模型中验证其功能，证明其能够恢复甘油三酯水解活性，并改善脂质代谢异常，为遗传性脂解障碍的治疗提供实验依据。
2. **文献名称**: "Expression, purification, and characterization of human adipose triglyceride lipase (PNPLA2) in Escherichia coli"
**作者**: Schweiger M, et al.
**摘要**: 报道了通过大肠杆菌系统高效表达和纯化人源PNPLA2重组蛋白的方法，并对其酶动力学特性进行分析，证实其特异性水解甘油三酯的功能。
3. **文献名称**: "Structural insights into the catalytic mechanism of PNPLA2 through recombinant protein crystallization"
**作者**: Grumati P, et al.
**摘要**: 通过重组PNPLA2蛋白的结晶和结构解析，揭示了其催化结构域的关键氨基酸残基及底物结合机制，为设计调控脂解的小分子药物奠定结构基础。
(注：上述文献为示例性概括，实际引用需核对具体论文信息。)
**Background of PNPLA2 Recombinant Protein**
PNPLA2 (patatin-like phospholipase domain-containing protein 2), also known as adipose triglyceride lipase (ATGL), is a key enzyme in lipid metabolism. It catalyzes the hydrolysis of triglycerides into free fatty acids and glycerol, serving as the rate-limiting step in lipolysis. This enzyme is highly expressed in adipose tissue but is also found in other tissues, including the liver, muscle, and heart. PNPLA2 plays a critical role in energy homeostasis by regulating lipid storage and mobilization, making it essential for maintaining metabolic balance.
Mutations in the *PNPLA2* gene are linked to neutral lipid storage diseases, such as Chanarin-Dorfman syndrome, characterized by excessive lipid accumulation in multiple organs. Dysregulation of PNPLA2 activity has also been associated with metabolic disorders, including obesity, insulin resistance, and non-alcoholic fatty liver disease (NAFLD). These connections highlight its importance in both physiological and pathological processes.
Recombinant PNPLA2 protein is produced using heterologous expression systems (e.g., *E. coli* or mammalian cells) to study its structure, function, and interactions. The purified protein enables in vitro analysis of enzymatic activity, substrate specificity, and inhibitor screening. It is also used to develop therapeutic strategies targeting lipid metabolism disorders. For instance, modulating PNPLA2 activity could offer novel approaches to treat obesity or NAFLD.
Research on PNPLA2 recombinant protein has advanced understanding of lipolytic pathways and its regulatory mechanisms, including interactions with coactivators like CGI-58 and inhibitors such as G0S2. These insights are crucial for deciphering metabolic networks and designing targeted therapies. Overall, PNPLA2 recombinant protein serves as a vital tool for both basic research and drug development in metabolic diseases.
×
